Literature DB >> 18456410

Local erythropoietin signaling enhances regeneration in peripheral axons.

C Toth1, J A Martinez, W Q Liu, J Diggle, G F Guo, N Ramji, R Mi, A Hoke, D W Zochodne.   

Abstract

Erythropoietin (EPO) and its receptor (EPO-R), mediate neuroprotection from axonopathy and apoptosis in the peripheral nervous system (PNS). We examined the impact and potential mechanisms of local EPO signaling on regenerating PNS axons in vivo and in vitro. As a consequence of injury, peripheral nerve axons and DRG neurons have a marked increase in the expression of EPO and EPO-R. Local delivery of EPO via conduit over 2 weeks to rat sciatic nerve following crush injury increased the density and maturity of regenerating myelinated axons growing distally from the crush site. In addition, EPO also rescued retrograde degeneration and atrophy of axons. EPO substantially increased the density and intensity of calcitonin gene-related peptide (CGRP) expression within outgrowing axons. Behavioral improvements in sensorimotor function also occurred in rats exposed to near nerve EPO delivery. EPO delivery led to decreased nuclear factor kappaB (NFkB) activation but increased phosphorylation of Akt and STAT3 within nerve and dorsal root ganglia neurons indicating rescue from an injury phenotype. Spinal cord explant studies also demonstrated a similar dose-dependent effect of EPO upon motor axonal outgrowth. Local EPO signaling enhances regenerating peripheral nervous system axons in addition to its known neuroprotection. Exogenous EPO may have a therapeutic role in a large number of peripheral nerve diseases through its impact on regeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456410     DOI: 10.1016/j.neuroscience.2008.03.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Authors:  Asha R Kallianpur; Todd Hulgan
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

2.  Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia.

Authors:  Rhonda Souvenir; Nancy Fathali; Robert P Ostrowski; Tim Lekic; John H Zhang; Jiping Tang
Journal:  Neurobiol Dis       Date:  2011-06-06       Impact factor: 5.996

Review 3.  Peripheral nerve injury and myelination: Potential therapeutic strategies.

Authors:  Max Modrak; M A Hassan Talukder; Khatuna Gurgenashvili; Mark Noble; John C Elfar
Journal:  J Neurosci Res       Date:  2019-10-13       Impact factor: 4.164

4.  Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment.

Authors:  Yanlu Zhang; Ye Xiong; Asim Mahmood; Yuling Meng; Zhongwu Liu; Changsheng Qu; Michael Chopp
Journal:  Brain Res       Date:  2010-07-21       Impact factor: 3.252

5.  Calnexin deficiency leads to dysmyelination.

Authors:  Allison Kraus; Jody Groenendyk; Karen Bedard; Troy A Baldwin; Karl-Heinz Krause; Michel Dubois-Dauphin; Jason Dyck; Erica E Rosenbaum; Lawrence Korngut; Nansi J Colley; Simon Gosgnach; Douglas Zochodne; Kathryn Todd; Luis B Agellon; Marek Michalak
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

6.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

7.  Erythropoietin promotes Schwann cell migration and assembly of the provisional extracellular matrix by recruiting beta1 integrin to the cell surface.

Authors:  Gen Inoue; Alban Gaultier; Xiaoqing Li; Elisabetta Mantuano; George Richardson; Kazuhisa Takahashi; W Marie Campana
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

8.  The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Authors:  Ilaria Cervellini; Ezia Bello; Roberta Frapolli; Carla Porretta-Serapiglia; Norberto Oggioni; Annalisa Canta; Raffaella Lombardi; Francesca Camozzi; Ilaria Roglio; Roberto Cosimo Melcangi; Maurizio D'incalci; Giuseppe Lauria; Pietro Ghezzi; Guido Cavaletti; Roberto Bianchi
Journal:  Neurotox Res       Date:  2009-10-30       Impact factor: 3.911

9.  Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons.

Authors:  Munmun Chattopadhyay; Claire Walter; Marina Mata; David J Fink
Journal:  Brain       Date:  2009-02-24       Impact factor: 13.501

10.  Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis.

Authors:  C-H Lee; C-H Hong; W-T Yu; H-Y Chuang; S-K Huang; G-S Chen; T Yoshioka; M Sakata; W-T Liao; Y-C Ko; H-S Yu
Journal:  Br J Dermatol       Date:  2012-10       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.